FILE – In this Jan. 20, 2010 file photo, a subject’s waist is measured during an obesity prevention study in Chicago. Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market. Novo Nordisk reported another surge in profits and revenue during its most recent quarter with a big assist from Wegovy, an injectable treatment for weight loss approved by the Food and Drug Administration in 2021. (AP Photo/M. Spencer Green, File)AP Photo/M. Spencer Green, File
Severe obesity is on the rise in the US
About 4 in 10 Americans have obesity overall and about 1 in 10 have severe obesity